Gary Lynch

1 stories · following the connections

Business

RespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development

By Nasdaq OMXDec 18, 2017, 1:45 PM UTC